ILLUMINA CAMBRIDGE LIMITED

1. ILLUMINA CAMBRIDGE LIMITED 2008-01-04 → present
2. SOLEXA LIMITED 1998-10-09 → 2008-01-04
3. INTERCEDE 1356 LIMITED 1998-09-02 → 1998-10-09

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for the period to 31 December 2026.”

Group structure

1. ILLUMINA CAMBRIDGE LIMITED · parent
   1. Illumina India Biotechnology Private Ltd 1% · India · sale of Illumina, Inc. group instruments and consumables
   2. Illumina Singapore Pte. Ltd. 100% · Singapore · manufacturer and sale of Illumina, Inc. group instruments and consumables
   3. Illumina Canada ULC 100% · Canada · sale of Illumina, Inc. group instruments and consumables
   4. BlueBee Holding B.V. 100% · Netherlands · cloud-based software company that provided genomics analysis solutions for research and clinical customers
   5. Emedgene Technologies Ltd 100% · Israel · data driven AI solutions company for genomic diagnostics
   6. Illumina Colombia S.A.S. 100% · Colombia · sale of Illumina, Inc. group instruments and consumables
   7. Illumina Mexico Productos de Biotecnologia 99% · Mexico · sale of Illumina, Inc. group instruments and consumables
   8. Illumina Uruguay SRL 99% · Uruguay · dormant and in the process of being dissolved
   9. Illumina Chile SpA 100% · Chile · dormant throughout 2024 and subsequently dissolved

Significant events

• “In December 2024 Illumina Cambridge opened a branch in Singapore for the purpose of undertaking R&D activity. 30 employees transitioned from Illumina Singapore Pte. Ltd., which is wholly owned by Illumina Cambridge, into the branch. The branch accounts have been incorporated within those of Illumina Cambridge.”
• “On the 28th March 2025 a dividend of $105,000,000 was received from Illumina Singapore Pte. Ltd.”
• “On the 28th March 2025 a dividend of $155,000,000 was paid by Illumina Cambridge to Illumina, Inc.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -4%

  £2,402,504,818 → £2,305,862,861

• Cash

  +19.1%

  £41,836,916 → £49,811,712

• Net assets

  -14.1%

  £730,896,961 → £627,869,533

• Employees

  -11.2%

  823 → 731

• Operating profit

  -46.7%

  £151,659,007 → £80,876,205

• Profit before tax

  -9.8%

  £415,614,529 → £374,874,722

• Wages

  -4%

  £72,584,136 → £69,710,156

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers